GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Selectis Health Inc (OTCPK:GBCS) » Definitions » Debt-to-EBITDA

Selectis Health (Selectis Health) Debt-to-EBITDA

: -3.72 (As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Selectis Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $12.07 Mil. Selectis Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $25.49 Mil. Selectis Health's annualized EBITDA for the quarter that ended in Dec. 2023 was $-10.09 Mil. Selectis Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -3.72.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Selectis Health's Debt-to-EBITDA or its related term are showing as below:

GBCS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -286.71   Med: 17.37   Max: 47.99
Current: -286.71

During the past 13 years, the highest Debt-to-EBITDA Ratio of Selectis Health was 47.99. The lowest was -286.71. And the median was 17.37.

GBCS's Debt-to-EBITDA is ranked worse than
100% of 419 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs GBCS: -286.71

Selectis Health Debt-to-EBITDA Historical Data

The historical data trend for Selectis Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Selectis Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.39 5.91 19.35 23.27 -286.71

Selectis Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.92 1.93 -8.70 -6.22 -3.72

Competitive Comparison

For the Medical Care Facilities subindustry, Selectis Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Selectis Health Debt-to-EBITDA Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Selectis Health's Debt-to-EBITDA falls into.



Selectis Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Selectis Health's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.07 + 25.489) / -0.131
=-286.71

Selectis Health's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.07 + 25.489) / -10.088
=-3.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Selectis Health  (OTCPK:GBCS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Selectis Health Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Selectis Health's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Selectis Health (Selectis Health) Business Description

Traded in Other Exchanges
N/A
Address
8480 E. Orchard Road, Suite 4900, Greenwood Village, CO, USA, 80111
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. It operates assisted living, independent living and skilled nursing facilities in Arkansas, Georgia, Ohio, and Oklahoma providing a wide array of living services, speech, occupational, physical therapies, social services, and other rehabilitation and healthcare services.
Executives
Lance Baller director 10173 BRIARGROVE WAY, HIGHLANDS RANCH CO 80126
David J. Furstenberg director 1226 WIND CHIME DR., WATERFORD MI 48327
Brandon Thall officer: CFO 8480 E. ORCHARD ROAD, STE. 4900, GREENWOOD VILLAGE CO 80111
Christopher R. Barker officer: President and COO 8480 E. ORCHARD ROAD, STE. 4900, GREENWOOD VILLAGE CO 80111
Neuman Clifford L Esq director, 10 percent owner 6800 NORTH 79TH STREET, SUITE # 200, NIWOT CO 80503
Downs John H Jr director PO BOX 723040, ATLANTA GA 30339
Andrew L Sink director P O BOX 531124, BIRMINGHAM AL 35253
Joshua Mandell director C/O GLOBAL HEALTHCARE REIT, INC., 8480 E. ORCHARD RD., STE. 4900, GREENWOOD VILLAGE CO 80111
Adam Desmond director PO BOX 2036, CARBONDALE CO 81623
Jacob Taylor officer: Secretary 6800 N. 79TH ST., STE. 200, NIWOT CO 80503
Sandra Lee Kuwica officer: Vice President of Finance C/O GLOBAL HEALTHCARE REIT, INC., 8480 E. ORCHARD RD., STE. 3600, GREENWOOD VILLAGE CO 80111
Steven Mark Bathgate director 5350 S ROSLYN, SUITE 380, ENGLEWOOD CO 80111
Philip S Scarborough officer: Chief Financial Officer 595 ATLANTA STREET, SUITE D, ROSWELL GA 30075
Christopher F Brogdon director, officer: President 2 BUCKHEAD PLAZA, 3050 PEACHTREE ROAD, SUITE 570, ATLANTA GA 30305
Brogdon Connie B other: spouse of Director/President 6000 LAKE FORREST DR, STE 200, ATLANTA GA 30328